RPRX - Repros Therapeutics Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1011
Avg. Estimate-0.320-1.07-1.01
Low Estimate-0.320-1.07-1.01
High Estimate-0.320-1.07-1.01
Year Ago EPS-0.16-0.22-0.7-1.07
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1011
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago Sales5kN/A47kN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.17-0.14-0.22-0.28
EPS Actual-0.16-0.22-0.08-0.05
Difference0.01-0.080.140.23
Surprise %5.90%-57.10%63.60%82.10%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.320-1.07-1.01
7 Days Ago-0.320-1.07-1.01
30 Days Ago-0.320-1.07-1.01
60 Days Ago-0.320-1.07-1.01
90 Days Ago-0.320-1.07-1.01
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesRPRXIndustrySectorS&P 500
Current Qtr.-100.00%N/AN/A0.26
Next Qtr.N/AN/AN/A0.33
Current Year-52.90%N/AN/A0.09
Next Year5.60%N/AN/A0.15
Next 5 Years (per annum)27.90%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A